Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | flap structure-specific endonuclease 1 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Trypanosoma brucei | exonuclease, putative | flap structure-specific endonuclease 1 | 380 aa | 322 aa | 24.5 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0021 | 0.0773 | 0.1674 |
Mycobacterium tuberculosis | Bacterioferritin BfrB | 0.001 | 0 | 0.5 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.1584 | 1 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0021 | 0.0773 | 0.1674 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.2475 | 0.536 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0031 | 0.1584 | 0.3429 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.1001 | 0.2167 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0773 | 0.1565 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.001 | 0 | 0.5 |
Entamoeba histolytica | Flap nuclease, putative | 0.0031 | 0.1584 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2909 | 0.2314 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.5998 | 0.5302 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0021 | 0.0773 | 0.1674 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.2475 | 0.536 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.1001 | 0.2167 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0773 | 0.1565 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0021 | 0.0773 | 0.1674 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.4941 | 1 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0031 | 0.1584 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0773 | 0.1565 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.1096 | 0.2218 |
Plasmodium falciparum | flap endonuclease 1 | 0.0031 | 0.1584 | 0.5 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.1584 | 1 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0031 | 0.1584 | 0.5 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.001 | 0 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.0018 | 0.0615 | 0.1245 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.1268 | 0.2567 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.3081 | 0.2501 |
Mycobacterium tuberculosis | Probable bacterioferritin BfrA | 0.001 | 0 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.1268 | 0.2746 |
Echinococcus granulosus | flap endonuclease 1 | 0.0031 | 0.1584 | 0.3429 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0 | 0.5 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0031 | 0.1584 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.1096 | 0.035 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.1584 | 1 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.0828 | 0.006 |
Brugia malayi | Flap endonuclease-1 | 0.0031 | 0.1584 | 0.012 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.4619 | 1 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0031 | 0.1584 | 0.0878 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2695 | 0.2083 |
Schistosoma mansoni | flap endonuclease-1 | 0.0028 | 0.1358 | 0.2748 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0773 | 0.1565 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.1268 | 0.2746 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0031 | 0.1584 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.0615 | 0.1245 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.5612 | 0.5245 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.4619 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.2689 | 0.1417 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.1001 | 0.2025 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1122 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (binding) | = 0.7943 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.